Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Figure 2 from GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling
0
Zitationen
20
Autoren
2025
Jahr
Abstract
<p>Retrospective validation of GPSai. Model performance per major cancer category is shown for primary (<b>A</b>) and metastatic (<b>B</b>) tumors. Confusion matrices show numbers of each predicted tumor type in the boxes, with numbers of correctly predicted tumors (matching submitted diagnosis) in each category shown in the diagonal. PPV for each category is indicated by the bars on top, and sensitivity by the bars to the right. Prospective validation results are shown in Supplementary Fig. S8 and Supplementary Table S3. CNS, central nervous system.</p>
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.988 Zit.
TNM Classification of Malignant Tumours
1987 · 16.123 Zit.
A survey on deep learning in medical image analysis
2017 · 13.697 Zit.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.807 Zit.
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
2010 · 9.118 Zit.